TP53 and cancer: To our knowledge, overexpression of HMGB2 has been identified in several types of tumors, including hepatocellular carcinoma (HCC) and skin cancer, and has been involved in cancer progression and prognosis via interacting with RAGE, steroid receptors, p53 and p73 (14,15).